Amylin’s New Byetta Branding Plays Up Weight Loss
This article was originally published in The Pink Sheet Daily
Executive Summary
JP Morgan survey shows shift from injectable Byetta to convenient Januvia.
You may also be interested in...
Proxy War-Front Latest: Amylin, Vanda Rocked By Dissident Shareholders
In tough times, patience for failing drugs and restructuring programs wears particularly thin.
Proxy War-Front Latest: Amylin, Vanda Rocked By Dissident Shareholders
In tough times, patience for failing drugs and restructuring programs wears particularly thin.
Novo Nordisk’s Liraglutide Set For March 2009 PDUFA
Phase II study of once-weekly GLP-1 analog is under way, with results due next year.